scholarly journals Current management of choledocholithiasis after bariatric surgery

2021 ◽  
Vol 8 (12) ◽  
pp. 3749
Author(s):  
Khalid M. Alzahrani ◽  
Sumayyah A. Jafri ◽  
Hafiz A. Hamdi

The increasing prevalence of obesity all over world has led to a growing number of metabolic and bariatric surgeries. Bariatric surgery is more effective for weight loss than medical therapy, with Roux-en-Y gastric bypass (RYGB) being considered the gold standard of care over the past decade. Bariatric surgery and the subsequent weight loss are associated with an increased risk for the development of gallstone formation. Common bile duct stones prevalence around 10% among patients with symptomatic gallbladder stones. Choledocholithiasis can be technically challenging problem to treat in patients post-laparoscopic RYGB (LRYGB) or a biliopancreatic diversion (BPD/DS) due to the altered upper gastrointestinal anatomy. This review describes the different treatment options of common bile duct stones after malabsorptive bariatric surgery, success rate, and adverse effects of each treatment modality including enteroscopy-assisted endoscopic retrograde cholangiopancreatography (EA-ERCP), percutaneous transhepatic cholangiography (PTC), endoscopic ultrasound-directed transgastric retrograde cholangiopancreatography (EDGE), and laparoscopic-assisted ERCP (LAERCP).

1995 ◽  
Vol 15 (3) ◽  
pp. 212-214
Author(s):  
Saleh M. Al Amri ◽  
Rashed S. Al Rashed ◽  
Ibrahim A. Al Mofleh

2020 ◽  
Vol 91 (6) ◽  
pp. AB365
Author(s):  
Hirokazu Saito ◽  
Yuki Iwagoi ◽  
Takehiko Koga ◽  
Kana Noda ◽  
Masafumi Sakaguchi ◽  
...  

2017 ◽  
Vol 05 (09) ◽  
pp. E809-E817 ◽  
Author(s):  
Hirokazu Saito ◽  
Tatsuyuki Kakuma ◽  
Yoshihiro Kadono ◽  
Atsushi Urata ◽  
Kentaro Kamikawa ◽  
...  

Abstract Background and study aims Endoscopic removal of asymptomatic common bile duct stones (CBDS) is generally recommended. Although many reports have described the risk of complications in endoscopic retrograde cholangiopancreatography (ERCP), no studies have addressed this problem in the context of asymptomatic CBDS. This study examines the risk of complications arising in ERCP for asymptomatic CBDS. Patients and methods This retrospective study included 425 patients with naive papilla who underwent therapeutic ERCP for choledocholithiasis at 2 institutions in Japan for 2 years. The risk of complications was examined in patients who were divided into the asymptomatic and symptomatic CBDS groups. We used propensity score analysis to adjust for confounding effects. Results Complications were observed in 32 (7.5 %) of the 425 patients. Of the 358 patients with symptomatic CBDS, 14 patients (3.9 %) had complications. In contrast, of the 67 patients with asymptomatic CBDS, 18 patients (26.9 %) had complications. Propensity score analysis revealed that asymptomatic CBDS was a significant risk factor, with a significantly higher incidence of complications compared with symptomatic CBDS (odds ratio, 5.3). Moderate to severe complications were observed in 15 of 18 patients (83.3 %) in the asymptomatic CBDS group, with significantly more moderate to severe complications than those in the symptomatic CBDS (odds ratio, 6.7). Conclusions Asymptomatic CBDS carried a high risk of ERCP-related complications, and these were often more severe. In asymptomatic CBDS, endoscopic treatment should be carefully performed after considering the patient’s background, and detailed explanation of its possible complications should be given to patients in advance.


2000 ◽  
Vol 7 (4) ◽  
pp. 224-231 ◽  
Author(s):  
Terrence H. Liu ◽  
Frank G. Moody

Sign in / Sign up

Export Citation Format

Share Document